GOVX · GeoVax Labs
AI read · Bad for GOVX
The AI's read
The smaller loss offers some relief. But lower research spending partly followed the end of a federal contract and cuts to two programs, while manufacturing costs rose for GEO-MVA. With no sales and funding expected to last only into December, continued operations are the central concern.